HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yokoyama, I. Articles by Nagai, R. Search for Related Content PubMed PubMed Citation Articles by Yokoyama, I. Articles by Nagai, R.

Coronary Microangiopathy in Type 2 Diabetic Patients: Relation to Glycemic Control, Sex, and Microvascular Angina Rather Than to Coronary Artery Disease

Departments of Cardiovascular Medicine, Radiology, and Metabolic Diseases, University of Tokyo, Tokyo, Japan

Correspondence: For correspondence or reprints contact: Ikuo Yokoyama, MD, Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655.

ABSTRACT

Coronary microangiopathy is a major complication in diabetics. However, the presence of independent factors in association with coronary microangiopathy in patients with non-insulin-dependent diabetes mellitus (NIDDM) or the difference in coronary microangiopathy between diabetics with coronary artery disease (CAD) and those with microvascular angina is unclear. Methods: Nineteen patients with NIDDM and microvascular angina, 18 patients with NIDDM and CAD, and 17 age-matched control subjects were studied. Myocardial segments that were perfused by angiographically normal coronary arteries were studied. The baseline myocardial blood flow (MBF) and the MBF during dipyridamole administration were measured using PET and ¹³N-ammonia, after which the myocardial flow reserve (MFR) was calculated to assess coronary microangiopathy. Results: The baseline MBF was comparable among NIDDM patients with microvascular angina, NIDDM patients with CAD, and control subjects. However, the MBF during dipyridamole administration was significantly lower in NIDDM patients with microvascular angina (126 ± 42.7 mL/min/100 g) than that in either NIDDM patients with CAD (210 ± 70.1 mL/min/100 g; P < 0.01) or control subjects (293 ± 159 mL/min/100 g; P < 0.01), as was the MFR (NIDDM with microvascular angina, 1.90 ± 0.73; NIDDM with CAD, 2.59 ± 0.81 [P < 0.01]; control subjects, 3.69 ± 1.09 [P < 0.01]). Multivariate stepwise regression analysis showed that, among the factors considered, glycemic control was independently related to the MFR (r = 0.838; P < 0.05). Conclusion: Glycemic control appears to be essential for coronary microangiopathy in NIDDM.

Key Words: hyperglycemia • non-insulin-dependent diabetes mellitus • flow reserve • atherosclerosis • coronary microangiopathy

This article has been cited by other articles:

				H. R. Schelbert Coronary circulatory function abnormalities in insulin resistance insights from positron emission tomography. J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S3 - S8. [Abstract] [Full Text] [PDF]

				G. Orasanu and J. Plutzky The pathologic continuum of diabetic vascular disease. J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S35 - S42. [Abstract] [Full Text] [PDF]

				I. G. Poornima, P. Parikh, and R. P. Shannon Diabetic Cardiomyopathy: The Search for a Unifying Hypothesis Circ. Res., March 17, 2006; 98(5): 596 - 605. [Abstract] [Full Text] [PDF]

				R. Lautamaki, K.E. J. Airaksinen, M. Seppanen, J. Toikka, R. Harkonen, M. Luotolahti, R. Borra, J. Sundell, J. Knuuti, and P. Nuutila Insulin Improves Myocardial Blood Flow in Patients With Type 2 Diabetes and Coronary Artery Disease Diabetes, February 1, 2006; 55(2): 511 - 516. [Abstract] [Full Text] [PDF]

				J. O. Prior, M. J. Quinones, M. Hernandez-Pampaloni, A. D. Facta, T. H. Schindler, J. W. Sayre, W. A. Hsueh, and H. R. Schelbert Coronary Circulatory Dysfunction in Insulin Resistance, Impaired Glucose Tolerance, and Type 2 Diabetes Mellitus Circulation, May 10, 2005; 111(18): 2291 - 2298. [Abstract] [Full Text] [PDF]

				K. Doi, K. Hasegawa, M. Fujita, A. Yamazato, K. Yamanaka, M. Watanabe, K. Tambara, and M. Komeda Clinical characteristics relevant to myocardial cell apoptosis: analysis of pericardial fluid Interactive CardioVascular and Thoracic Surgery, June 1, 2004; 3(2): 359 - 362. [Abstract] [Full Text] [PDF]

				I. Yokoyama, Y. Inoue, T. Moritan, K. Ohtomo, and R. Nagai Impaired myocardial vasodilatation during hyperaemic stress is improved by simvastatin but not by pravastatin in patients with hypercholesterolaemia Eur. Heart J., April 2, 2004; 25(8): 671 - 679. [Abstract] [Full Text] [PDF]

				E. Picano Diabetic cardiomyopathy: the importance of being earliest J. Am. Coll. Cardiol., August 6, 2003; 42(3): 454 - 457. [Full Text] [PDF]

				Y. Yu, K. Ohmori, I. Kondo, L. Yao, T. Noma, T. Tsuji, K. Mizushige, and M. Kohno Correlation of functional and structural alterations of the coronary arterioles during development of type II diabetes mellitus in rats Cardiovasc Res, November 1, 2002; 56(2): 303 - 311. [Abstract] [Full Text] [PDF]